Menu
Home
News
Open submenu
About MedNous
Open submenu
Research Directory
Open submenu
Contact Us
Open submenu
Close submenu
News
News
Appointments
Events
Close submenu
About MedNous
Who We Are
Editorial Board
Editorial Policy
Close submenu
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Close submenu
Contact Us
Contact Form
Skip to main content
2 April 2025
Last updated:
Sunday 30 March 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Trends in investment for cell and gene therapies
Read more
A new cell therapy approach to Alzheimer's disease
Read more
Strengths and shortcomings of new EU rules for ATMPs
Read more
Direct cell reprogramming: Mogrify and Astellas to address hearing loss
Read more
A cell therapy approach for hearing loss
Read more
Cell Therapy: TreeFrog Therapeutics on the go
Read more
A record year for the financing of ATMPs
Read more
Top 10 financing events for ATMPs in 2020
Read more
Integrated product development for ATMPs
Read more
The role of base and prime editing in therapeutics
Read more
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Next page
››
Last page
Last »
Close menu
